2026年全球血脂檢查市場報告

近年來，血脂檢測市場發展迅速，預計將從2025年的116.1億美元成長到2026年的126.1億美元，複合年成長率達8.6%。過去幾年的成長可歸因於多種因素，例如心血管疾病盛行率的上升、常規健康檢查計畫的推廣、人們對膽固醇管理意識提升、自動化檢測設備的引入以及診斷服務可及性的改善。

預計未來幾年，血脂檢查市場將維持強勁成長，到2030年市場規模將達到177.9億美元，複合年成長率（CAGR）為9.0%。預測期內的成長要素包括：對預防性醫療保健的日益重視、對家庭診斷需求的成長、數位健康平台的整合、人工智慧輔助診斷解讀的日益普及以及人群健康篩檢計畫的擴展。預測期內的主要趨勢包括：照護現場血脂檢測的普及、自動化血脂分析儀的使用增加、對預防性心血管篩檢的需求成長、家用血脂檢測套組的普及以及對早期風險評估的日益重視。

預計心血管疾病和糖尿病的盛行率上升將推動血脂檢查市場的成長。心血管疾病是一組影響心臟和血管的疾病，而糖尿病是一種影響胰島素分泌並導致血糖值升高的代謝紊亂疾病，這兩種疾病都在推動血脂檢查的需求。這種診斷工具對於識別有心血管疾病風險或已患有心血管疾病的人至關重要。它還有助於監測治療效果，使醫療保健提供者能夠制定個人化的治療方案，以達到目標血脂水平並降低患病風險。例如，根據美國心臟學會（總部位於美國的非營利醫療組織）2025年9月的數據，預計2023年全球因心血管疾病死亡的人數將達到約1,920萬人。因此，心血管疾病和糖尿病盛行率的不斷上升預計將推動血脂檢查市場的成長。

血脂檢查市場的主要參與者正致力於開發先進的診斷解決方案，包括基於脂蛋白(a)的檢測，以增強心血管風險評估。基於脂蛋白(a)的檢測是一種診斷測試，用於測量血液中脂蛋白(a)的水平，使臨床醫生能夠識別心血管疾病高風險族群，並制定更個人化的治療方案。例如，2024年5月，總部位於瑞士的生物技術和診斷公司羅氏(F. Hoffmann-La Roche AG)在獲得美國食品藥物管理局(FDA)的突破性醫療設備認定後，推出了Tina-quant Lp(a) RxDx檢測。此檢測可量化每公升血液中脂蛋白(a)顆粒的數量，為心血管風險評估提供標準化的、具有臨床意義的生物標記。此檢測旨在與羅氏現有的血清工作站系統和cobas平台整合，從而支持有關降低脂蛋白(a)治療的知情臨床決策，提高診斷準確性，並促進個人化血脂管理方法的更廣泛應用。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球血脂檢查市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 生物技術、基因組學和精準醫學
  • 數位化、雲端運算、巨量資料、網路安全
  • 物聯網、智慧基礎設施和互聯生態系統
  • 人工智慧（AI）和自主人工智慧
  • 工業4.0和智慧製造
• 主要趨勢
  • 照護現場血脂檢測的普及率不斷提高
  • 自動血脂分析儀的使用日益增多
  • 對預防性心血管篩檢的需求日益成長
  • 擴大家用血脂檢測套組的使用範圍
  • 越來越重視早期風險評估

第5章 終端用戶產業市場分析

• 醫院
• 診斷診所
• 病理檢查室
• 專科部門和醫生診所
• 門診手術中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球血脂檢查市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 全球血脂檢查市場規模、比較及成長率分析
• 全球血脂檢查市場表現：規模與成長，2020-2025年
• 全球血脂檢查市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

• 按產品和服務分類
• 設備、套件和服務
• 透過處方模式
• 處方箋和非處方藥檢測
• 透過使用
• 高血脂症、高三酸甘油脂血症、遺傳性高膽固醇症、低脂蛋白血症、坦齊爾氏症、動脈粥狀硬化及其他適應症
• 最終用戶
• 醫院、專科診所和醫生診所、病理檢查室、診斷診所、參考檢查室、學術和研究機構以及其他最終用戶
• 按類型細分：設備
• 自動化分析儀、就地檢驗設備、光強度
• 按類型細分：套裝
• 膽固醇、高密度脂蛋白和低密度脂蛋白檢測試劑盒，三酸甘油酯檢測套組
• 按類型細分：服務
• 檢測服務、診斷服務、健康體檢服務

第10章 區域與國家分析

• 全球血脂檢查市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
• 全球血脂檢查市場：依國家、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 血脂檢查市場：競爭格局及市場佔有率（2024年）
• 血脂檢查市場：公司評估矩陣
• 血脂檢查市場：公司概況
  • Abbott Laboratories
  • Beckman Coulter Inc.
  • F. Hoffmann-La Roche Ltd.
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific Inc.

第37章：其他領先和創新企業

• PTS Diagnostics, Quest Diagnostics Incorporated, Alere Inc., Boston Heart Diagnostics Corporation, Eurofins Scientific SE, Spark Diagnostics Pvt Ltd., Everlywell Inc., Horiba ABX SAS, Siemens Healthcare GmbH, Nova Biomedical Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin SpA, EKF Diagnostics Holdings plc, Ortho Clinical Diagnostics LLC

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年血脂檢查市場：提供新機會的國家
• 2030年血脂檢查市場：新興細分市場機會
• 2030年血脂檢查市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Lipid panel testing refers to a blood test that measures the levels of various lipids or fats in the blood. This test is commonly used to assess an individual's risk of developing cardiovascular disease.

The main products and services related to lipid panel testing include devices, kits, and services. Devices, such as analyzer machines, are the equipment used to perform lipid panel testing. The various prescription modes for lipid panel testing include prescription-based testing and over-the-counter (OTC) based testing. Lipid panel testing is applied in various conditions such as hyperlipidemia, hypertriglyceridemia, familial hypercholesterolemia, hypo-lipoproteinamia, Tangier disease, atherosclerosis, and others. The diverse end users of lipid panel testing products and services encompass hospitals, specialty clinics and physician offices, pathology laboratories, diagnostic clinics, ambulatory surgical centers, reference laboratories, academic and research institutes, and others.

Tariffs are impacting the lipid panel testing market by increasing costs of imported diagnostic reagents, testing kits, automated analyzers, and electronic components used in laboratory and point-of-care systems. Diagnostic laboratories and healthcare providers in North America and Europe are most affected due to reliance on imported consumables and devices, while Asia-Pacific faces cost pressures on test kit manufacturing and exports. These tariffs are raising testing costs and affecting procurement cycles. However, they are also encouraging local production of diagnostic kits, regional reagent manufacturing, and supply chain diversification.

The lipid panel testing market research report is one of a series of new reports from The Business Research Company that provides lipid panel testing market statistics, including lipid panel testing industry global market size, regional shares, competitors with a lipid panel testing market share, detailed lipid panel testing market segments, market trends and opportunities, and any further data you may need to thrive in the lipid panel testing industry. This lipid panel testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lipid panel testing market size has grown strongly in recent years. It will grow from $11.61 billion in 2025 to $12.61 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, expansion of routine health screening programs, growing awareness of cholesterol management, adoption of automated laboratory diagnostics, improved access to diagnostic services.

The lipid panel testing market size is expected to see strong growth in the next few years. It will grow to $17.79 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing focus on preventive healthcare, rising demand for home diagnostics, integration of digital health platforms, growing use of AI-assisted diagnostic interpretation, expansion of population health screening initiatives. Major trends in the forecast period include increasing adoption of point-of-care lipid testing, rising use of automated lipid analyzers, growing demand for preventive cardiovascular screening, expansion of home-based lipid testing kits, enhanced focus on early risk assessment.

The anticipated increase in cardiovascular and diabetic diseases is poised to drive the growth of the lipid panel testing market. Cardiovascular disease, a cluster of conditions affecting the heart and blood vessels, along with diabetes, a metabolic disorder impacting insulin production and leading to elevated blood sugar levels, collectively contribute to the demand for lipid panel testing. This diagnostic tool is crucial for identifying individuals at risk of developing cardiovascular diseases or those already affected. Additionally, it aids in monitoring treatment effectiveness, enabling healthcare providers to adjust treatment plans to attain target lipid levels and mitigate the risk of further ailments. For example, in September 2025, data from the American College of Cardiology, a United States-based nonprofit medical association, indicated that global deaths due to cardiovascular diseases reached approximately 19.2 million in 2023. Consequently, the escalating prevalence of cardiovascular and diabetic diseases is expected to propel the lipid panel testing market forward.

Leading companies operating in the lipid panel testing market are increasingly concentrating on the development of advanced diagnostic solutions, including lipoprotein(a)-based assays, to strengthen cardiovascular risk evaluation. An Lp(a)-based assay is a diagnostic test that measures lipoprotein(a) levels in the blood, helping clinicians identify individuals with a higher risk of cardiovascular disease and enabling more tailored treatment approaches. For instance, in May 2024, F. Hoffmann-La Roche AG, a Switzerland-based biotechnology and diagnostics company, introduced the Tina-quant Lp(a) RxDx assay after obtaining Breakthrough Device Designation from the United States Food and Drug Administration. This assay quantifies the number of Lp(a) particles per litre of blood, providing a standardized and clinically actionable biomarker for cardiovascular risk assessment. Designed for integration with Roche's existing serum work area systems and cobas platforms, the assay supports informed clinical decision-making related to Lp(a)-lowering therapies, enhances diagnostic precision, and encourages broader adoption of personalized lipid management approaches.

In July 2024, Hydreight Technologies Inc., a United States-based provider of at-home blood testing services, entered into a partnership with a national laboratory to broaden its testing offerings. Through this collaboration, Hydreight aims to expand access to a wider portfolio of laboratory tests across all fifty states in the United States, thereby improving patient convenience, accessibility, and turnaround times. The national laboratory involved is a United States-based provider of clinical laboratory testing services, specializing in comprehensive diagnostic testing and detailed reporting for both healthcare professionals and individual consumers.

Major companies operating in the lipid panel testing market are Abbott Laboratories, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., PTS Diagnostics, Quest Diagnostics Incorporated, Alere Inc., Boston Heart Diagnostics Corporation, Eurofins Scientific SE, Spark Diagnostics Pvt Ltd., Everlywell Inc., Horiba ABX SAS, Siemens Healthcare GmbH, Nova Biomedical Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin S.p.A., EKF Diagnostics Holdings plc, Ortho Clinical Diagnostics LLC

North America was the largest region in the lipid panel testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the global lipid panel testing market during the forecast period. The regions covered in the lipid panel testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lipid panel testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The lipid panel testing market consists of revenues earned by entities by providing high cholesterol testing and lipoprotein analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The lipid panel testing market also includes sales of cholesterol test kit, lipid profile analyzer, and cholesterol self-test kit which are used in providing testing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lipid Panel Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses lipid panel testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lipid panel testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lipid panel testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product And Services: Devices; Kits; Services
• 2) By Prescription Mode: Prescription-Based Testing; OTC-Based Testing
• 3) By Application: Hyperlipidemia; Hypertriglyceridemia; Familial Hypercholesterolemia; Hypo-Lipoproteinemia; Tangier Disease; Atherosclerosis; Other Applications
• 4) By End User: Hospital; Specialty Clinics And Physician Offices; Pathology Laboratories; Diagnostic Clinics; Reference Laboratories; Academic And Research Institutes; Other End-Users
• Subsegments:
• 1) By Devices: Automated Analyzers; Point-Of-Care Testing Devices; Spectrophotometers
• 2) By Kits: Test Kits For Cholesterol; HDL And LDL Kits; Triglyceride Test Kits
• 3) By Services: Laboratory Testing Services; Diagnostic Services; Health Screening Services
• Companies Mentioned: Abbott Laboratories; Beckman Coulter Inc.; F. Hoffmann-La Roche Ltd.; Randox Laboratories Ltd.; Thermo Fisher Scientific Inc.; PTS Diagnostics; Quest Diagnostics Incorporated; Alere Inc.; Boston Heart Diagnostics Corporation; Eurofins Scientific SE; Spark Diagnostics Pvt Ltd.; Everlywell Inc.; Horiba ABX SAS; Siemens Healthcare GmbH; Nova Biomedical Corporation; Bio-Rad Laboratories Inc.; Danaher Corporation; DiaSorin S.p.A.; EKF Diagnostics Holdings plc; Ortho Clinical Diagnostics LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Lipid Panel Testing Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Lipid Panel Testing Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Lipid Panel Testing Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Lipid Panel Testing Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Industry 4.0 & Intelligent Manufacturing
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Point-Of-Care Lipid Testing
  • 4.2.2 Rising Use Of Automated Lipid Analyzers
  • 4.2.3 Growing Demand For Preventive Cardiovascular Screening
  • 4.2.4 Expansion Of Home-Based Lipid Testing Kits
  • 4.2.5 Enhanced Focus On Early Risk Assessment

5. Lipid Panel Testing Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Diagnostic Clinics
• 5.3 Pathology Laboratories
• 5.4 Specialty Clinics And Physician Offices
• 5.5 Ambulatory Surgical Centers

6. Lipid Panel Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Lipid Panel Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Lipid Panel Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Lipid Panel Testing Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Lipid Panel Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Lipid Panel Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Lipid Panel Testing Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Lipid Panel Testing Market Segmentation

• 9.1. Global Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Devices, Kits, Services
• 9.2. Global Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Prescription-Based Testing, OTC-Based Testing
• 9.3. Global Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hypo-Lipoproteinemia, Tangier Disease, Atherosclerosis, Other Applications
• 9.4. Global Lipid Panel Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital, Specialty Clinics And Physician Offices, Pathology Laboratories, Diagnostic Clinics, Reference Laboratories, Academic And Research Institutes, Other End-Users
• 9.5. Global Lipid Panel Testing Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Automated Analyzers, Point-Of-Care Testing Devices, Spectrophotometers
• 9.6. Global Lipid Panel Testing Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Test Kits For Cholesterol, HDL And LDL Kits, Triglyceride Test Kits
• 9.7. Global Lipid Panel Testing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Laboratory Testing Services, Diagnostic Services, Health Screening Services

10. Lipid Panel Testing Market Regional And Country Analysis

• 10.1. Global Lipid Panel Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Lipid Panel Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Lipid Panel Testing Market

• 11.1. Asia-Pacific Lipid Panel Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Lipid Panel Testing Market

• 12.1. China Lipid Panel Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Lipid Panel Testing Market

• 13.1. India Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Lipid Panel Testing Market

• 14.1. Japan Lipid Panel Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Lipid Panel Testing Market

• 15.1. Australia Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Lipid Panel Testing Market

• 16.1. Indonesia Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Lipid Panel Testing Market

• 17.1. South Korea Lipid Panel Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Lipid Panel Testing Market

• 18.1. Taiwan Lipid Panel Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Lipid Panel Testing Market

• 19.1. South East Asia Lipid Panel Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Lipid Panel Testing Market

• 20.1. Western Europe Lipid Panel Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Lipid Panel Testing Market

• 21.1. UK Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Lipid Panel Testing Market

• 22.1. Germany Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Lipid Panel Testing Market

• 23.1. France Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Lipid Panel Testing Market

• 24.1. Italy Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Lipid Panel Testing Market

• 25.1. Spain Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Lipid Panel Testing Market

• 26.1. Eastern Europe Lipid Panel Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Lipid Panel Testing Market

• 27.1. Russia Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Lipid Panel Testing Market

• 28.1. North America Lipid Panel Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Lipid Panel Testing Market

• 29.1. USA Lipid Panel Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Lipid Panel Testing Market

• 30.1. Canada Lipid Panel Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Lipid Panel Testing Market

• 31.1. South America Lipid Panel Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Lipid Panel Testing Market

• 32.1. Brazil Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Lipid Panel Testing Market

• 33.1. Middle East Lipid Panel Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Lipid Panel Testing Market

• 34.1. Africa Lipid Panel Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Lipid Panel Testing Market, Segmentation By Product And Services, Segmentation By Prescription Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Lipid Panel Testing Market Regulatory and Investment Landscape

36. Lipid Panel Testing Market Competitive Landscape And Company Profiles

• 36.1. Lipid Panel Testing Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Lipid Panel Testing Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Lipid Panel Testing Market Company Profiles
  • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Beckman Coulter Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Randox Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Lipid Panel Testing Market Other Major And Innovative Companies

• PTS Diagnostics, Quest Diagnostics Incorporated, Alere Inc., Boston Heart Diagnostics Corporation, Eurofins Scientific SE, Spark Diagnostics Pvt Ltd., Everlywell Inc., Horiba ABX SAS, Siemens Healthcare GmbH, Nova Biomedical Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin S.p.A., EKF Diagnostics Holdings plc, Ortho Clinical Diagnostics LLC

38. Global Lipid Panel Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Lipid Panel Testing Market

40. Lipid Panel Testing Market High Potential Countries, Segments and Strategies

• 40.1 Lipid Panel Testing Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Lipid Panel Testing Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Lipid Panel Testing Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer